{"id":30920,"date":"2025-10-23T14:39:37","date_gmt":"2025-10-23T13:39:37","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=30920"},"modified":"2025-11-13T17:04:33","modified_gmt":"2025-11-13T16:04:33","slug":"appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/","title":{"rendered":"Appel transnational conjoint 2026 : nouveaux traitements pour lutter contre la r\u00e9sistance aux antimicrobiens\u00a0"},"content":{"rendered":"\n<p>Le Partenariat europ\u00e9en sur la r\u00e9sistance aux antimicrobiens dans le cadre de l&#8217;initiative \u00ab Une seule sant\u00e9 \u00bb (EUP OHAMR) lance le 18 novembre 2025 un appel \u00e0 projets international visant \u00e0 explorer de nouveaux traitements pour lutter contre la r\u00e9sistance aux antimicrobiens. L&#8217;appel, intitul\u00e9 \u00ab Traitements et respect des protocoles th\u00e9rapeutiques \u00bb, rassemble 37 organismes de financement issus de 28 pays diff\u00e9rents, pour un budget total estim\u00e9 \u00e0 plus de 28 millions d&#8217;euros. L&#8217;appel est financ\u00e9 par 37 organisations de financement nationales (pour la France, l\u2019ANR), et par l\u2019Union Europ\u00e9enne.<\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-1 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"800\" height=\"400\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/Appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens.png\" alt=\"\" class=\"wp-image-30921\" srcset=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/Appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens.png 800w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/Appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens-300x150.png 300w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/Appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens-768x384.png 768w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-bottom is-layout-flow wp-block-column-is-layout-flow\">\n<p><strong>Joint transnational call 2026: New treatments to tackle AMR<\/strong><\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-white-color has-luminous-vivid-orange-background-color has-text-color has-background has-link-color wp-element-button\" href=\"https:\/\/ohamr.eu\/funding\/funding-opportunities\/call-2025-new-treatments-to-tackle-amr\/\">En savoir plus<\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:15px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Le Partenariat europ\u00e9en sur la r\u00e9sistance aux antimicrobiens dans le cadre de l&#8217;initiative \u00ab Une seule sant\u00e9 \u00bb (EUP OHAMR) lance le 18 novembre 2025 un appel \u00e0 projets international visant \u00e0 explorer de nouveaux traitements pour lutter contre la r\u00e9sistance aux antimicrobiens. L&#8217;appel, intitul\u00e9 \u00ab Traitements et respect des protocoles th\u00e9rapeutiques \u00bb, rassemble 37 [&hellip;]<\/p>\n","protected":false},"author":275,"featured_media":30921,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31,38],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Appel transnational conjoint 2026 : nouveaux traitements pour lutter contre la r\u00e9sistance aux antimicrobiens\u00a0 - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Appel transnational conjoint 2026 : nouveaux traitements pour lutter contre la r\u00e9sistance aux antimicrobiens\u00a0 - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-23T13:39:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-13T16:04:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/Appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"supportmlcom\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"supportmlcom\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/\"},\"author\":{\"name\":\"supportmlcom\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5\"},\"headline\":\"Appel transnational conjoint 2026 : nouveaux traitements pour lutter contre la r\u00e9sistance aux antimicrobiens\u00a0\",\"datePublished\":\"2025-10-23T13:39:37+00:00\",\"dateModified\":\"2025-11-13T16:04:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/\"},\"wordCount\":110,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/Appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens.png\",\"articleSection\":[\"Actualit\u00e9s\",\"Appels \u00e0 projets\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/\",\"name\":\"Appel transnational conjoint 2026 : nouveaux traitements pour lutter contre la r\u00e9sistance aux antimicrobiens\u00a0 - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/Appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens.png\",\"datePublished\":\"2025-10-23T13:39:37+00:00\",\"dateModified\":\"2025-11-13T16:04:33+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/Appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/Appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens.png\",\"width\":800,\"height\":400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Appel transnational conjoint 2026 : nouveaux traitements pour lutter contre la r\u00e9sistance aux antimicrobiens\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5\",\"name\":\"supportmlcom\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Appel transnational conjoint 2026 : nouveaux traitements pour lutter contre la r\u00e9sistance aux antimicrobiens\u00a0 - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/","og_locale":"fr_FR","og_type":"article","og_title":"Appel transnational conjoint 2026 : nouveaux traitements pour lutter contre la r\u00e9sistance aux antimicrobiens\u00a0 - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2025-10-23T13:39:37+00:00","article_modified_time":"2025-11-13T16:04:33+00:00","og_image":[{"width":800,"height":400,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/Appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens.png","type":"image\/png"}],"author":"supportmlcom","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"supportmlcom"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/"},"author":{"name":"supportmlcom","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5"},"headline":"Appel transnational conjoint 2026 : nouveaux traitements pour lutter contre la r\u00e9sistance aux antimicrobiens\u00a0","datePublished":"2025-10-23T13:39:37+00:00","dateModified":"2025-11-13T16:04:33+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/"},"wordCount":110,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/Appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens.png","articleSection":["Actualit\u00e9s","Appels \u00e0 projets"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/","name":"Appel transnational conjoint 2026 : nouveaux traitements pour lutter contre la r\u00e9sistance aux antimicrobiens\u00a0 - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/Appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens.png","datePublished":"2025-10-23T13:39:37+00:00","dateModified":"2025-11-13T16:04:33+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/Appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/Appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens.png","width":800,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/appel-transnational-conjoint-2026-nouveaux-traitements-pour-lutter-contre-la-resistance-aux-antimicrobiens\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"Appel transnational conjoint 2026 : nouveaux traitements pour lutter contre la r\u00e9sistance aux antimicrobiens\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5","name":"supportmlcom"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-16 04:00:13","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/30920"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/275"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=30920"}],"version-history":[{"count":9,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/30920\/revisions"}],"predecessor-version":[{"id":31045,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/30920\/revisions\/31045"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/30921"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=30920"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=30920"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=30920"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}